Laboratory of Dr. Reddy (Dr. Reddy's), the major pharmaceutical company in India, is trying to get the fourth largest producer of generic drugs in Germany. Dr. Reddy quoted $ 570 million in a competitive bidding situation. Chief negotiator, the company is preparing to close the deal, if selected. Students will examine, the chief negotiator, such as: is the price right is a necessary strategic, value-added will be purchasing as it may be the interaction of the full extent and how management should proceed with the integration. (A) is positioned in front of the case of the acquisition and hints of possible risks. In the case of the application, laboratories, Dr. Reddy (B), product # 908M65, positioned two years after the acquisition and discusses the main risks which, as he turned around, brought the viability of the business model into question. "Hide
by Jean-Louis Schaan, Ramasastry Chandrasekhar Source: Richard Ivey School of Business Foundation 17 pages. Publication Date: September 18, 2008. Prod. #: 908M64-PDF-ENG
Related Case Solutions & Analyses:
Setting You Up to Fail
How Institutional Investors Think About Real Estate
iPremier (A): Denial of Service Attack (Graphic Novel Version)
Shareholder Democracy: Does Gretchen Get It Right
Haier Hefei Electronics Co. (A)
HRM Course Overview Note
Washington Post: Balancing Technology and Human Resources by Design
Building the Virtual Lab: Global Licensing and Partnering at Merck
Performance Management Report
Rank Xerox (A): Global Transfer of Best Practices (Condensed)
